Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05832567 · ClinicalTrials.gov registry record · NA

Mechanisms of Open and Hidden Placebo in Stroke Recovery

A NA study of Stroke and Hemiparesis, sponsored by Spaulding Rehabilitation Hospital.

Recruiting
Registry status
NA
Development phase
56
Enrollment target
1
Study location

NCT05832567 is a NA study of Stroke and Hemiparesis that is actively recruiting participants, run by Spaulding Rehabilitation Hospital. The registered enrollment target is 56 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05832567, a NA study of Stroke and Hemiparesis, is actively recruiting participants, sponsored by Spaulding Rehabilitation Hospital.

RECRUITING
Registry status
NA
Development phase
56 participants
Enrollment target
1
Study location

Study Summary

This trial aims to investigate whether placebo in isolation (open and hidden) has a specific neural signature in stroke subjects thus providing a novel mechanism to explain placebo effects that can be used to ultimately enhance stroke rehabilitation therapies.

Conditions Studied

Interventions

  • DEVICE Active rTMS
  • DEVICE Sham rTMS
  • DIETARY_SUPPLEMENT Open Placebo

Study Locations (1)

Massachusetts

  • Spaulding Hospital Cambridge - Cambridge

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2023-09-11
Est. Completion 2026-06-30
Phase NA

Sponsor

Spaulding Rehabilitation Hospital

101 total trials

What the Registry Record Tells You About NCT05832567

The ClinicalTrials.gov registry entry for NCT05832567 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is Spaulding Rehabilitation Hospital, which has 101 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Stroke appearing as the primary indexed condition, and to 3 interventions - of which Active rTMS is the first listed.

NCT05832567 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05832567 about?

NCT05832567 is a clinical study titled "Mechanisms of Open and Hidden Placebo in Stroke Recovery". This trial aims to investigate whether placebo in isolation (open and hidden) has a specific neural signature in stroke subjects thus providing a novel mechanism to explain placebo effects that can be used to ultimately enhance stroke rehabilitation therapies.

What is the current status of trial NCT05832567?

This trial is currently recruiting. It is a NA study. The enrollment target is 56 participants. The study started on 2023-09-11. Estimated completion is 2026-06-30.

What conditions does trial NCT05832567 study?

This clinical trial studies the following conditions: Stroke, Hemiparesis.

What interventions are being tested in trial NCT05832567?

The interventions under investigation include: Active rTMS (DEVICE), Sham rTMS (DEVICE), Open Placebo (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05832567?

This trial is sponsored by Spaulding Rehabilitation Hospital, which has 101 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05832567 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.